James A. Geraghty - Aug 7, 2024 Form 4 Insider Report for PIERIS PHARMACEUTICALS, INC. (PIRS)

Role
Director
Signature
/s/ Thomas Bures
Stock symbol
PIRS
Transactions as of
Aug 7, 2024
Transactions value $
$1
Form type
4
Date filed
10/28/2024, 05:18 PM
Previous filing
Jun 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PIRS Series F Preferred Stock, par value $0.001 per share Purchase $1.00 +1 $1.00* 1 Aug 7, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 7, 2024, the Reporting Person purchased one (1) share of Series F Preferred Stock, par value $0.001 per share (the "Preferred Stock"), of Pieris Pharmaceuticals, Inc. (the "Issuer") from the Issuer for cash consideration of $1.00. The Preferred Stock has the rights, preferences, privileges and restrictions set forth in the Certificate of Designation of Series F Preferred Stock filed by the Issuer with the Nevada Secretary of State on August 7, 2024 (the "Series F COD"), including the right to have 25,000,000 votes and to vote together with the outstanding shares of the Issuer's common stock as a single class exclusively with respect to such voting proposals defined in the Series F COD.